Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models

被引:0
|
作者
Xu Steven Xu
Adrian Dunne
Holly Kimko
Partha Nandy
An Vermeulen
机构
[1] Johnson & Johnson Pharmaceutical R&D,Clinical Pharmacology, Advanced PK
[2] Janssen Research & Development,PD Modeling and Simulation
[3] University College Dublin,Clinical Pharmacology, Advanced PK
关键词
Pharmacokinetics; Parameter estimate; BQL;
D O I
暂无
中图分类号
学科分类号
摘要
The objectives of the simulation study were to evaluate the impact of BQL data on pharmacokinetic (PK) parameter estimates when the incidence of BQL data is low (e.g. ≤10%), and to compare the performance of commonly used modeling methods for handling BQL data such as data exclusion (M1) and likelihood-based method (M3). Simulations were performed by adapting the method of a recent publication by Ahn et al. (J Phamacokinet Pharmacodyn 35(4):401–421, 2008). The BQL data in the terminal elimination phase were created at frequencies of 1, 2.5, 5, 7.5, and 10% based on a one- and a two-compartment model. The impact of BQL data on model parameter estimates was evaluated based on bias and imprecision. The simulations demonstrated that for the one-compartment model, the impact of ignoring the low percentages of BQL data (≤10%) in the elimination phase was minimal. For the two-compartment model, when the BQL incidence was less than 5%, omission of the BQL data generally did not inflate the bias in the fixed-effect parameters, whereas more pronounced bias in the estimates of inter-individual variability (IIV) was observed. The BQL data in the elimination phase had the greatest impact on the volume of distribution estimate of the peripheral compartment of the two-compartment model. The M3 method generally provided better parameter estimates for both PK models than the M1 method. However, the advantages of the M3 over the M1 method varied depending on different BQL censoring levels, PK models and parameters. As the BQL percentages decreased, the relative gain of the M3 method based on more complex likelihood approaches diminished when compared to the M1 method. Therefore, it is important to balance the trade-off between model complexity and relative gain in model improvement when the incidence of BQL data is low. Understanding the model structure and the distribution of BQL data (percentage and location of BQL data) allows selection of an appropriate and effective modeling approach for handling low percentages of BQL data.
引用
收藏
页码:423 / 432
页数:9
相关论文
共 50 条
  • [21] Quality quandaries: Impact of only below limit of detection data
    Hamada, M. S.
    Weaver, B. P.
    Schmidt, C. C.
    QUALITY ENGINEERING, 2016, 28 (03) : 358 - 364
  • [22] ON THE COVARIANCE BETWEEN PARAMETER ESTIMATES IN MODELS OF TWIN DATA
    WILLIAMS, CJ
    BIOMETRICS, 1993, 49 (02) : 557 - 568
  • [23] A BAYESIAN APPROACH FOR PK/PD MODELING WITH PD DATA BELOW LIMIT OF QUANTIFICATION
    Zhou, Huafeng
    Hartford, Alan
    Tsai, Kuenhi
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2012, 22 (06) : 1220 - 1243
  • [24] Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?
    El Hassani, Mehdi
    Liebchen, Uwe
    Marsot, Amelie
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (04) : 419 - 436
  • [25] Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model
    Thi Huyen Tram Nguyen
    Comets, Emmanuelle
    Mentre, France
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2012, 39 (05) : 499 - 518
  • [26] Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model
    Thi Huyen Tram Nguyen
    Emmanuelle Comets
    France Mentré
    Journal of Pharmacokinetics and Pharmacodynamics, 2012, 39 : 499 - 518
  • [27] Likelihood based approaches to handling data below the quantification limit using NONMEM VI
    Jae Eun Ahn
    Mats O. Karlsson
    Adrian Dunne
    Thomas M. Ludden
    Journal of Pharmacokinetics and Pharmacodynamics, 2008, 35 : 401 - 421
  • [28] Likelihood based approaches to handling data below the quantification limit using NONMEM VI
    Ahn, Jae Eun
    Karlsson, Mats O.
    Dunne, Adrian
    Ludden, Thomas M.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2008, 35 (04) : 401 - 421
  • [29] SENSITIVITY OF PARAMETER ESTIMATES TO DATA SPECIFICATION IN MODE CHOICE MODELS
    TRAIN, KE
    TRANSPORTATION, 1978, 7 (03) : 301 - 309
  • [30] Utilization of data below the analytical limit of quantitation in pharmacokinetic analysis and modeling: promoting interdisciplinary debate
    Hecht, Max
    Veigure, Ruta
    Couchman, Lewis
    Barker, Charlotte I. S.
    Standing, Joseph F.
    Takkis, Kalev
    Evard, Hanno
    Johnston, Atholl
    Herodes, Koit
    Leito, Ivo
    Kipper, Karin
    BIOANALYSIS, 2018, 10 (15) : 1229 - 1248